Publications by authors named "Andre M Pilon"

Claim this Profile
R
Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidism.
Venkatesh Krishnan, Yanfei L Ma, Catherine Z Chen, Natasha Thorne, Heather Bullock, Andre M Pilon

Br J Pharmacol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Financial and Research Models for Pediatric Orphan Drug Development - Focus on the NCATS TRND Program.
John Shen, Gurmit Grewal, Andre M Pilon, John C McKew

Pharmaceut Med· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NIH TRND program: successes in preclinical therapeutic development.
John C McKew, Andre M Pilon

Trends Pharmacol Sci· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide ChIP-Seq reveals a dramatic shift in the binding of the transcription factor erythroid Kruppel-like factor during erythrocyte differentiation.
Andre M Pilon, Subramanian S Ajay, Swathi Ashok Kumar, Laurie A Steiner, Praveen F Cherukuri

Blood· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Failure of terminal erythroid differentiation in EKLF-deficient mice is associated with cell cycle perturbation and reduced expression of E2F2.
Andre M Pilon, Murat O Arcasoy, Holly K Dressman, Serena E Vayda, Yelena D Maksimova

Mol Cell Biol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations in expression and chromatin configuration of the alpha hemoglobin-stabilizing protein gene in erythroid Kruppel-like factor-deficient mice.
Andre M Pilon, Douglas G Nilson, Dewang Zhou, Jose Sangerman, Tim M Townes

Mol Cell Biol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concentrated RD114-pseudotyped MFGS-gp91phox vector achieves high levels of functional correction of the chronic granulomatous disease oxidase defect in NOD/SCID/beta -microglobulin-/- repopulating mobilized human peripheral blood CD34+ cells.
Sebastian Brenner, Narda L Whiting-Theobald, Gilda F Linton, Kevin L Holmes, Mindy Anderson-Cohen, André M Pilon

Blood· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis